National Bank Of Canada /fi/ »

Allogene Therapeutics shares owned by National Bank Of Canada /fi/

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by National Bank Of Canada /fi/ from 13F filings

Historical chart of National Bank Of Canada /fi/ investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by National Bank Of Canada /fi/ consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by National Bank Of Canada /fi/

Quarter filed Position value Share count Share price at filing
2025-12-31 $680 500 1.36
2025-09-30 $615 500 1.23
2025-06-30 $527 467 1.13

More positions owned by National Bank Of Canada /fi/

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Rbc Cad (RY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Shopify Cl A Sub Vtg Shs (SHOP)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Cibc Cad (CM)

View all positions for National Bank Of Canada /fi/

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Patient Square Capital
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Millennium Management
Two Sigma Investments
Wildcat Capital Management
Two Sigma Advisers
State Street Corporation

View all funds holding Allogene Therapeutics